Company Overview
Mission
To provide leadership, education and innovation in male reproductive healthcare with revolutionary products that promise accuracy, efficiency and accessibility.
Who we are
ContraVac, located in Charlottesville, VA, develops products for male reproductive healthcare in cooperation with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia which is directed by ContraVac's founder, Dr. John Herr, Ph.D. ContraVac is dedicated to developing and commercializing research discoveries into innovative diagnostics for male reproductive health care. Through an in-license agreement with the University of Virginia Patent Foundation, ContraVac has obtained exclusive world-wide rights to certain University of Virginia patents related to sperm specific antigens, their complementary antibody reagents and their methods of use.
Our Products and Markets
ContraVac's family of SpermCheck products have been developed to meet the needs of millions of men who seek actionable information about their fertility health but wish to test themselves at home to avoid the indignities associated with traditional semen analysis. SpermCheck Vasectomy will be commercially available in March 2009 and SpermCheck Fertility in June 2009.
